Claims Processing Instructions for National Coverage Determination 20.33 - Transcatheter Edge-to-Edge Repair [TEER] for Mitral Valve Regurgitation
The purpose of this Change Request (CR) is to inform MACs that on January 19, 2021, CMS expanded coverage of mitral valve TEER procedures for the treatment of functional mitral regurgitation (MR), and maintained coverage of TEER for the treatment of degenerative MR through coverage with evidence development (CED) and with mandatory registry participation.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: September 08, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.